|
Glenn Saldanha is the Managing Director & CEO of Glenmark Pharmaceuticals Limited. He holds a Bachelor’s [graduate] degree in Pharmacy and an M.B.A. [post graduation degree] from Leonard Stern School of Business, NYU. Glenn joined Glenmark Pharmaceuticals in 1998 as Director and took over as Managing Director & CEO in 2001. Glenn joined Eli Lily’s global marketing team soon after gradu 5ac ating from NYU. His last assignment was with Price Waterhouse Coopers USA. As consultant at PWC, he had opportunity to work with top pharmaceutical companies, like Rhone Poulenc Rhorer, Bristol Myers Squibb, Astra, Merck and Smith Kline Beecham. Glenn has been instrumental in growing Glenmark from being an India formulations business in 1999 to a global firm with interests spanning discovery research, India and international formulations, and API. The company has grown at a compounded annual rate in excess of 34% over the past 5 years and is now among the few Indian firms with a successful drug discovery program. | 